Molecular Markers in Thyroid Cancer

Completed

Conditions studied: Thyroid Cancer

In brief

The purpose of this study is to evaluate how common gene mutations are in benign and malignant thyroid lesions.

Key facts

Study ID

NCT00598364

Run by

OHSU Knight Cancer Institute

People needed

847

Starts

2007-02-01

Expected to finish

2010-10-01

Last updated by the study team

2014-12-08

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 1 - 100
• Benign or malignant thyroid lesion, other malignancy or no thyroid abnormality
• Pathologic specimen available for analysis
• Ability to provide informed consent (for prospective study, Part Two)
• Age greater than age 18 (for normal controls)

You may not qualify if…

• Patients without adequate data for analysis
• Histopathologic or cytopathologic diagnosis of for medullary thyroid carcinoma (not derived from the thyroid follicular epithelium), thyroid lymphoma
• Unwilling to participate or unable to provide informed consent

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.